$733.57+12.24 (+1.70%)
Curtiss-Wright Corporation, together with its subsidiaries, provides engineered products, solutions, and services mainly to aerospace and defense, commercial nuclear power, process, and industrial markets worldwide.
Curtiss-Wright Corporation in the Industrials sector is trading at $733.57. Wall Street consensus targets $788.17 (6 analysts), implying a +7.4% move over the next 12 months. The stock is currently near its 52-week high of $760.72, remaining 17.8% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Curtiss-Wright Corporation, together with its subsidiaries, provides engineered products, solutions, and services mainly to aerospace and defense, commercial nuclear power, process, and industrial markets worldwide. It operates through three segments...
Curtiss-Wright (CW) is back in focus after Q1 2026 results topped earnings expectations, with revenue, margins, and EPS all improving across segments and management lifting full-year guidance alongside higher R&D and M&A spending plans. See our latest analysis for Curtiss-Wright. Despite the strong Q1 news, Curtiss-Wright’s share price has eased slightly over the past month. However, a year-to-date share price return of 28.09% and a 5-year total shareholder return of 481.41% point to momentum...
HEICO gains momentum with strong aerospace presence, solid liquidity and low debt, underscoring its growth outlook across commercial and defense markets.
Curtiss-Wright (CW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
RKLB stock soars, but Neutron development risks, supply-chain constraints and reliance on government programs remain key challenges.